Ruplizumab (Anti-TNFSF5 / CD40L / CD154)Ruplizumab (Anti-TNFSF5 / CD40L / CD154)
Move your mouse over image or click to enlarge

Ruplizumab (Anti-TNFSF5 / CD40L / CD154)

Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.
Cat# Size Price Qty Buy
A3100-1mg*25 1mg*25
£2,432.00
A3100-1mg*5 1mg*5
£794.00
A3100-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3100

Related Documents